series-a
Stage
1
Investors
About
Memento Medicines is a Boston-based biotech company developing biologic therapies for retinal diseases, including bispecific antibodies that combine Tie2 agonism with VEGF inhibition to treat ocular conditions.
Explore Memento Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.